Liz McFaddin is a Senior Scientific Lead in Discovery Technology and Platforms at Eli Lilly and Company, a position they have held since 2025. Previously, Liz served as a Principal Scientist in Medicinal Chemistry at Loxo Oncology at Lilly and held roles as an Associate Medicinal Chemist and Senior Scientist at Loxo Oncology, Inc. They began their career as a Research Associate at Crestone Pharma and gained early experience as a Chemistry Intern at N30 Pharmaceuticals. Liz earned a Bachelor of Arts in Molecular, Cellular, and Developmental Biology from the University of Colorado at Boulder, completed in 2011.
This person is not in any teams
This person is not in any offices